Bright Minds Biosciences (OTCQB: <a href= "https://www.otcmarkets.com/stock/BMBIF/quote">BMBIF</a>), is a biotechnology company focused on developing novel treatments for neuropsychiatry disorders, epilepsy and pain. Dr. Gideon Shapiro, Vice President of Discovery joins us to discuss the safety and efficacy of psychedelic treatments and how Bright Minds' treatments differ from conventional medicine. <a href= "https://www.otcmarkets.com/files/OTCQBPodcast_BrightMindsBiosciences_Season5Episode32.pdf"> View Podcast Transcript for Bright Minds Biosciences</a>

Bright Minds Biosciences (OTCQB: BMBIF), is a biotechnology company focused on developing novel treatments for neuropsychiatry disorders, epilepsy and pain. Dr. Gideon Shapiro, Vice President of Discovery joins us to discuss the safety and efficacy of psychedelic treatments and how Bright Minds' treatments differ from conventional medicine. View Podcast Transcript for Bright Minds Biosciences

Bright Minds Biosciences (OTCQB: <a href="https://www.otcmarkets.com/stock/BMBIF/quote" rel="noopener noreferrer">BMBIF</a>), is a biotechnology company focused on developing novel treatments for neuropsychiatry disorders, epilepsy and pain. Dr. Gideon Shapiro, Vice President of Discovery joins us to discuss the safety and efficacy of psychedelic treatments and how Bright Minds' treatments differ from conventional medicine. <a href="https://www.otcmarkets.com/files/OTCQBPodcast_BrightMindsBiosciences_Season5Episode32.pdf" rel="noopener noreferrer"> View Podcast Transcript for Bright Minds Biosciences</a>

Bright Minds Biosciences

OTC Markets presents our podcast series on the OTCQB Market, where we interview the entrepreneurs behind the companies that trade on the venture market.

Share Bright Minds Biosciences

Sign up to save your podcasts

Bright Minds Biosciences

Bright Minds Biosciences